Filter
378
Filtered Results: 378
Text search:
Lopinavir/Ritonavir
Featured
Recommendations
54
New Publications
92
Language
Document type
No document type
212
Guidelines
97
Studies & Reports
29
Fact sheets
15
Manuals
13
Resource Platforms
4
Training Material
3
Strategic & Response Plan
3
Infographics
2
Countries / Regions
India
16
Brazil
12
Tanzania
11
Latin America and the Carribbean
10
Paraguay
10
South Africa
10
Nepal
8
Mozambique
8
Kenya
7
Germany
6
Russia
6
Namibia
6
Rwanda
5
Nigeria
5
Senegal
5
Malawi
5
Congo, Democratic Republic of
5
Ethiopia
5
Bangladesh
4
Uganda
4
Colombia
3
Ukraine
3
Burkina Faso
3
Global
3
Haiti
3
Cambodia
3
Bolivia
3
Argentina
3
Angola
3
Zambia
3
Myanmar / Burma
3
Madagascar
3
Thailand
2
Lesotho
2
Ghana
2
Benin
2
China
2
Chile
2
Cameroon
2
Peru
2
Zimbabwe
2
Africa
2
Venezuela
2
West and Central Africa
2
Middle East and North Africa
2
France
2
Spain
2
East and Southern Africa
2
Botswana
2
Ecuador
2
North Macedonia
1
Tajikistan
1
Switzerland
1
El Salvador
1
Turkey
1
Sierra Leone
1
Togo
1
Iran
1
Albania
1
Canada
1
Congo-Brazzaville
1
Niger
1
Burundi
1
Austria
1
Philippines
1
Asia
1
Guinea-Bissau
1
Western and Central Europe
1
Luxembourg
1
Belgium
1
Côte d’Ivoire / Ivory Coast
1
Eastern Europe
1
Djibouti
1
Central African Republic
1
Mali
1
Bhutan
1
South Sudan
1
Indonesia
1
Liberia
1
Solomon Islands
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
198
Clinical Guidelines
36
Women & Child Health
11
Public Health
5
Key Resources
4
Pharmacy & Technologies
4
Capacity Building
3
Toolboxes
HIV
95
COVID-19
80
Pharmacy
29
TB
21
Mental Health
3
Ebola & Marburg
3
Caregiver
2
NTDs
2
Conflict
2
Global Health Education
1
AMR
1
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD...
The term "Programmatic Management of Drug Resistant TB" (PMD...
Almost half (46%) of the world’s 1.7 million children living with HIV were not on treatment in 2020 and 150 000 children were newly infected with HIV, four times more than the 2020 target of 40 000
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
A elaboração das Diretrizes para Diagnóstico e Tratamento da COVID-19 é uma resposta rápida ao enfrentamento da COVID-19, diante da declaração de pandemia pela Organização Mundial de Saúde (OMS) e das iniciativas do Ministério da Saúde para enfrentamento dessa nova situação no Brasil. ...
Research Article
Karo et al. BMC Infectious Diseases 2014, 14:148 http://www.biomedcentral.com/1471-2334/14/148
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar...
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
published in 2020, included a special insert mappi...
Guideline
SAJHIVMED DECEMBER 2013, Vol. 14, No. 4
